# Evaluate the Effect of Dietary Supplement Combined Exercise Among Patients With Sarcopenia Comorbid With Lung Disease

> **NCT05926713** · NA · RECRUITING · sponsor: **Orient Europharma Co., Ltd.** · enrollment: 100 (estimated)

## Conditions studied

- Sarcopenia
- COPD
- ILD

## Interventions

- **DIETARY_SUPPLEMENT:** Sarcojoint®
- **BEHAVIORAL:** supervised exercise

## Key facts

- **NCT ID:** NCT05926713
- **Lead sponsor:** Orient Europharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-01
- **Primary completion:** 2032-10-31
- **Final completion:** 2032-10-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05926713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05926713, "Evaluate the Effect of Dietary Supplement Combined Exercise Among Patients With Sarcopenia Comorbid With Lung Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05926713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*